Better Therapeutics seeks FDA nod for diabetes treatment in 2023

Better Therapeutics (Nasdaq:BTTX) shares ticked up on fourth-quarter results and projections for its flagship product in 2023.

Related Keywords

Frank Karbe ,Massdevice Medtech , ,San Francisco Based ,Wall Street ,Better Therapeutics ,